5 results for author:"Axen E." in Literature citations
Results Customize
› Repeat search in UniProtKB (2)
| N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors. Barf T., Lehmann F., Hammer K., Haile S., Axen E., Medina C., Uppenberg J., Svensson S., Rondahl L., Lundback T. Bioorg. Med. Chem. Lett. 19:1745-1748(2009) · Mapped (1) |
| Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors. Ringom R., Axen E., Uppenberg J., Lundback T., Rondahl L., Barf T. Bioorg. Med. Chem. Lett. 14:4449-4452(2004) · Mapped (1) |
| Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Lehmann F., Haile S., Axen E., Medina C., Uppenberg J., Svensson S., Lundbaeck T., Rondahl L., Barf T. Bioorg. Med. Chem. Lett. 14:4445-4448(2004) · UniProtKB (1) |
| Cloning, structure, and expression of a cDNA encoding vitamin D3 25-hydroxylase. Postlind H., Axen E., Bergman T., Wikvall K. Biochem. Biophys. Res. Commun. 241:491-497(1997) · UniProtKB (1) |
| Purification and characterization of a vitamin D3 25-hydroxylase from pig liver microsomes. Axen E., Bergman T., Wikvall K. Biochem. J. 287:725-731(1992) · UniProtKB (1) |